In this session, Nadine shows why biology should be viewed as a true platform technology - programmable, scalable, and capable of transforming sectors from medicine to manufacturing.
Advances in genome engineering (such as CRISPR), AI-driven design, and lab automation now make it possible to design and build with biology faster, cheaper, and more reliably than ever.
These tools are enabling innovations such as engineered microbes that convert waste into valuable chemicals, enzymes that replace polluting industrial processes, climate-resilient crops and cell-based meat to secure the global food supply, and emerging possibilities like locally producing medicines on demand, self-healing materials grown from living cells, and plants designed to capture far greater amounts of carbon.
Participants will learn how these capabilities offer strategic advantages by driving sustainable production, strengthening supply chains, and creating novel bio-based products with unique qualities. Nadine will also explore the ethical and governance considerations that are essential to using this transformative power responsibly.